PPH Lawsuit Lawyers

Meridia Diet Pill

Meridia is another diet pill that has been taken off of the market due to the side effects and health concerns it raises. Meridia, like fen-phen, has been shown to increase an individual’s blood pressure and heart rate. While they have not yet linked it directly to primary pulmonary hypertension, there is a chance that the problem could develop.

Meridia was released to the consumers of the United States in 1998, roughly one year after fen-phen was pulled from all of the shelves. It was approved by the FDA in 1998 despite having been rejected in 1997 due to the side effects associated with the drug.

In 2002, the leading public citizen watchdog group filed a petition detailing the serious health problems that were related to the drug. They requested that the drug be pulled from the shelves and the FDA complied. This was too late for the 29 people that died due to Meridia as well as those who have now discovered serious cardiovascular problems as a result of the drug. By September 2001, there were more than 400 serious health problems reported that were attributed to Meridia.

The maker of Meridia, Abbott Laboratories, developed numerous marketing strategies designed to differentiate between Meridia and fen-phen. 8.5 Million people worldwide bought into their marketing plan. A variety of critics feel that pharmaceutical companies have taken advantage of one of the largest and most eager consumer groups by promoting diet pills with potentially deadly side effects.

If you have been diagnosed with primary pulmonary hypertension (PPH) following the prescription of a diet pill like fen-phen or Meridia, contact the PPH lawsuit attorneys of Williams Kherkher at 1-866-950-9000 to discuss your legal options and to schedule an initial consultation.